- Home
- TBLA vs IRMD Comparison
TBLA vs IRMD Comparison
Compare TBLA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBLA | IRMD |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TBLA | IRMD |
|---|---|---|
| Price | $4.05 | $86.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 2.9M | 111.2K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | ★ 1400.00 | 16.67 |
| EPS | ★ 220.00 | 0.86 |
| Revenue | ★ $1,912,040,000.00 | $83,814,000.00 |
| Revenue This Year | $7.63 | $12.38 |
| Revenue Next Year | $5.25 | $11.31 |
| P/E Ratio | ★ $0.02 | $102.16 |
| Revenue Growth | 8.26 | ★ 14.43 |
| 52 Week Low | $2.84 | $67.84 |
| 52 Week High | $5.71 | $107.90 |
Technical Indicators
Market Signals| Indicator | TBLA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.51 | 33.41 |
| Support Level | $3.99 | $82.87 |
| Resistance Level | $4.18 | $87.93 |
| Average True Range (ATR) | 0.23 | 3.25 |
| MACD | -0.09 | -0.74 |
| Stochastic Oscillator | 29.52 | 7.89 |
Price Performance
Historical ComparisonAbout TBLA Taboola.com Ltd.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.